Biomarkers for risk prediction of mortality
US-12517139-B2 · Jan 6, 2026 · US
This page is not indexed by search engines while we improve data quality.
Block Dirk patents
Block Dirk is listed as an inventor on 47 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Block Dirk |
| Total patents | 47 |
| First publication | Jan 6, 2015 |
| Latest publication | Jan 6, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Biomarkers for risk assessment and treatment monitoring in heart failure patients guided by natriuretic peptides
US-12117454-B2 · Oct 15, 2024 · US
IGFBP-7 as a marker of preeclampsia
US-11874282-B2 · Jan 16, 2024 · US
Circulating Angiopoietin-2 (Ang-2) for the prediction of recurrence of atrial fibrillation
US-11644472-B2 · May 9, 2023 · US
TnT BASED DIAGNOSIS OF PAROXYSMAL ATRIAL FIBRILLATION
US-2023062697-A1 · Mar 2, 2023 · US
Identification of patients with abnormal fractional shortening
US-2022412991-A1 · Dec 29, 2022 · US
Marker for statin treatment stratification in heart failure
US-11460474-B2 · Oct 4, 2022 · US
Assessing whether a subject shall be subjected to imaging based diagnostic
US-11454634-B2 · Sep 27, 2022 · US
IGFBP7 for prediction of risk of AKI when measured prior to surgery
US-11397187-B2 · Jul 26, 2022 · US
Marker for statin treatment stratification in heart failure
US-2022206015-A1 · Jun 30, 2022 · US
Recent patents
Latest publications not already listed above.
Biomarkers in the selection of therapy of heart failure
US-2022034910-A1 · Feb 3, 2022 · US
IGFBP7 for diagnosing diastolic dysfunction
US-11047866-B2 · Jun 29, 2021 · US
Use of Biomarkers in the Assessment of the Early Transition from Arterial Hypertension to Heart Failure
US-2021164969-A1 · Jun 3, 2021 · US
Use of IGFBP-7 in the assessment of heart failure
US-10996229-B2 · May 4, 2021 · US
Use of biomarkers in the assessment of the early transition from arterial hypertension to heart failure
US-10942175-B2 · Mar 9, 2021 · US
Biomarkers for risk prediction of mortality
US-2020371114-A1 · Nov 26, 2020 · US
Biomarkers for risk assessment and treatment monitoring in heart failure patients guided by natriuretic peptides
US-2020271670-A1 · Aug 27, 2020 · US
Biomarkers for risk assessment and treatment monitoring in heart failure patients guided by natriuretic peptides
US-10684291-B2 · Jun 16, 2020 · US
Use of igfbp-7 in the assessment of heart failure
US-2020064359-A1 · Feb 27, 2020 · US
Biomarkers for risk prediction of mortality
US-10557858-B2 · Feb 11, 2020 · US
Use of IGFBP-7 in the assessment of heart failure
US-10488422-B2 · Nov 26, 2019 · US
Circulating angiopoietin-2 (ang-2) for the prediction of recurrence of atrial fibrillation
US-2019353666-A1 · Nov 21, 2019 · US
Soluble st2 for the identification of progressors to lvh in the general population
US-2019279770-A1 · Sep 12, 2019 · US
Igfbp7 for diagnosing diastolic dysfunction
US-2019277861-A1 · Sep 12, 2019 · US
IGFBP7 for diagnosing diastolic dysfunction
US-10345315-B2 · Jul 9, 2019 · US
Marker for statin treatment stratification in heart failure
US-2019154706-A1 · May 23, 2019 · US
Use of mimecan in the assessment of heart failure
US-10234462-B2 · Mar 19, 2019 · US
Marker for statin treatment stratification in heart failure
US-10234464-B2 · Mar 19, 2019 · US
Igfbp-7 as a marker of preeclampsia
US-2018364248-A1 · Dec 20, 2018 · US
NTproBNP AND cTnT BASED THERAPY GUIDANCE IN HEART FAILURE
US-2018313850-A1 · Nov 1, 2018 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Roche Diagnostics Operations Inc | 37 |
| Roche Diagnostics Operations | 8 |
| Governing Council Univ Toronto | 4 |
| Univ Toronto | 3 |
| Block Dirk | 3 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| G01N33/6893 | 41 |
| G01N2800/325 | 32 |
| G01N2800/52 | 26 |
| G01N33/6887 | 24 |
| G01N2333/58 | 22 |